BEGIN:VCALENDAR
PRODID:-//Microsoft Corporation//Outlook 14.0 MIMEDIR//EN
VERSION:2.0
METHOD:PUBLISH
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
BEGIN:STANDARD
DTSTART:16011104T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:16010311T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
CLASS:PUBLIC
CREATED:20201102T181956Z
DESCRIPTION:Thank you for registering to the virtual session entitled "New
Developments in the GLP-1RA's and Insights from the 2020 Diabetes Canada G
uidelines”\nDate: Wednesday\, December 16th\, 2020\nTime: 7:00 p.m. to
9:15 p.m. EST\n\nInstructions to connect to the virtual session:\nYou may
access the Virtual Conference platform through the link on our conference
website below and entering the password: newglp\nhttps://events.myconfere
ncesuite.com/New_Developments_in_the_GLP-1RA/page/VirtualConferencePlatfor
m\nOnce you are on this link\, please click the “View the Webcast” but
ton .\nWhen joining the webcast\, please login using your full name. This
is required to confirm your attendance.\nYou may participate in the progra
m on any web browser\, however\, Google Chrome is recommended and no other
software is necessary. Once logged in\, there is a link that will allow y
ou to test your system – and should you have any issues\, please click o
n “Technical Support” on the bottom right hand side of the page\, and
we will assist you.\nProgram Agenda\nOpening Remarks\nDr. Lawrence Leiter
– 5 min\nMaking GLP-1 RAs orally bioavailable\nDr. Ronald Goldenberg –
15 min\nContrasting the glycemic and renal efficacy and safety of oral an
d injectable GLP-1 RAs\nDr. Lawrence Leiter – 20 min\nGLP-1 RAs and weig
ht loss\nDr. Sue Pedersen – 20 min\nGLP-1 RAs and cardiovascular outcome
s\nDr. Subodh Verma – 20 min\nFrom clinical trials to practical applicat
ion: Who is the right patient for GLP-1RA therapy?\nDr. Irene Hramiak–
20 min\nInteractive Discussion \nAll Faculty – 35 min\nClosing Remarks\n
Dr. Subodh Verma \nIf you have any questions please contact:\nS & L Soluti
ons\nPhone: 647-462-1138\nEmail: info@slsolutionsevents.ca\n\n
DTEND;TZID="Eastern Standard Time":20201216T211500
DTSTAMP:20201102T181956Z
DTSTART;TZID="Eastern Standard Time":20201216T190000
LAST-MODIFIED:20201102T181956Z
LOCATION:Virtual Session - Details below
PRIORITY:5
SEQUENCE:0
SUMMARY;LANGUAGE=en-ca:New Developments in the GLP-1RA's and Insights from
the 2020 Diabetes Canada Guidelines
TRANSP:OPAQUE
UID:040000008200E00074C5B7101A82E0080000000040A6ABEFF6AED601000000000000000
01000000090319BDCD18CC846B8148E124248ACB0
X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\nThank
you for registering to the virtual session entitled "\;New Developments in the GLP-1RA's and Insights from the 2
020 Diabetes Canada Guidelines”
\n\n
Date: \; \;
Wednesday\, December 16th\, 2020
\n\nTime: \; \; &nb
sp\; 7:00 p.m. to 9:15<
/SPAN> p.m. EST
\n\n
\n\n<
B>Instructions to connect to the virtual session:<
/FONT>
\n\nYou may access the Virtual Conference platform through the link on o
ur conference website below and entering the password: newglp
\n\n
https://events.myconference
suite.com/New_Developments_in_the_GLP-1RA/page/VirtualConferencePlatform
\n\nOnce you
are on this link\, please click the “View the Webcast” button .
<
/P>\n\n
When joining the webcast\, please
login using your full name. This is required to confirm your attendance.
\n\nYou may participate in the program on any web brows
er\, however\, Google Chrome is recommended and no other software is neces
sary. Once logged in\, there is a link that will allow you to test your sy
stem – and should you have any issues\, please click on “Technical Sup
port” on the bottom right hand side of the page\, and we will assist you
.
\n\nProgram Agenda
\n
\nOpening Remarks
\n\n
Dr. Lawrence Leiter – 5 min
\n\nMaking GLP-1 RAs orally bioavailable
\n\nDr.
Ronald Goldenberg – 15 min
\n\nContrasting the glycemic and renal efficacy
and safety of oral and injectable GLP-1 RAs
\n\nDr. Lawrence Leiter – 20 m
in
\n\nGLP-1 RAs and weight loss
\n\nDr. Sue Pedersen – 20 min<
/P>\n\n
GLP-1 RAs and
cardiovascular outcomes
\n\nDr. Subodh Verma – 20 min
\n
\nFrom clinical tria
ls to practical application: \; Who is the right patient for GLP-1RA t
herapy?
\n\nDr. Irene Hramiak– 20 min
\n\nInteractive Discussion \;
\n\nAl
l Faculty – 35 min
\n
\nClosing Remarks
\n\n
Dr. Subodh Verma
\n\nIf you have any questions please contact:
\n\nS &\; L Solut
ions
\nPhone:
647-462-1138
\nEmail: info@slsolutionsevents.ca<
SPAN LANG="en-ca">
\n\n
\n\n\n
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
X-MICROSOFT-CDO-IMPORTANCE:1
X-MICROSOFT-DISALLOW-COUNTER:FALSE
X-MS-OLK-AUTOFILLLOCATION:FALSE
X-MS-OLK-CONFTYPE:0
BEGIN:VALARM
TRIGGER:-PT15M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR